Glucagon is the key factor in the development of diabetes

Diabetologia

Volumn 59, Issue 7, 2016, Pages 1372-1375

  Lee, Young H ^a   Wang, May Yun ^a   Yu, Xin Xin ^a   Unger, Roger H ^a  

^a UNIVERSITY OF TEXAS SOUTHWESTERN MEDICAL CENTER   (United States)

Author keywords

GCGR Ab; Gcgr mice; Glucagon; Glucagon suppression; HbA1c; Insulin; Insulin:glucagon ratio; Review

Indexed keywords

GLUCAGON; GLUCAGON RECEPTOR; HEMOGLOBIN A1C; INSULIN; KETONE; LEPTIN RECEPTOR; RECEPTOR ANTIBODY; GLYCOSYLATED HEMOGLOBIN;

DIABETES MELLITUS; GLUCONEOGENESIS; GLUCOSE HOMEOSTASIS; GLUCOSE TOLERANCE; HUMAN; HYPERGLUCAGONEMIA; HYPERGLYCEMIA; INSULIN DEFICIENCY; INSULIN DEPENDENT DIABETES MELLITUS; INSULIN SENSITIVITY; MONOTHERAPY; NON INSULIN DEPENDENT DIABETES MELLITUS; NONHUMAN; PANCREAS ISLET ALPHA CELL; PANCREAS ISLET BETA CELL; PRIORITY JOURNAL; REVIEW; ANIMAL; METABOLISM; MOUSE; PATHOLOGY;

ANIMALS; DIABETES MELLITUS; GLUCAGON; HEMOGLOBIN A, GLYCOSYLATED; HUMANS; INSULIN; MICE;

EID: 84975221895     PISSN: 0012186X     EISSN: 14320428     Source Type: Journal    
DOI: 10.1007/s00125-016-3965-9     Document Type: Review

References (16)

1. Muller WA, Faloona GR, Unger RH (1973) Hyperglucagonemia in diabetic ketoacidosis. Its prevalence and significance. Am J Med 54:52–57
2. Muller WA, Girardier L, Seydoux J, Berger M, Renold AE, Vranic M (1978) Extra hepatic glucagon and glucagonlike immunoreactivity in depancreatized dogs. A quantitative assessment of secretion rates and anatomical delineation of sources. J Clin Investig 62:124–132
3. Unger RH (1976) The Banting Memorial Lecture 1975. Diabetes and the alpha cell. Diabetes 25:136–151
4. Dobbs R, Sakurai H, Sasaki H et al (1975) Glucagon: role in the hyperglycemia of diabetes mellitus. Science 187:544–547
5. Lee Y, Wang MY, Du QX, Charron MJ, Unger RH (2011) Glucagon receptor knockout prevents insulin-deficient type 1 diabetes in mice. Diabetes 60:391–397
6. Lee Y, Berglund ED, Wang MY et al (2012) Metabolic manifestations of insulin deficiency do not occur without glucagon action. Proc Natl Acad Sci U S A 109:14972–14976
7. Cahill CF Jr (1971) Banting Memorial Lecture 1971. Physiology of insulin in man. Diabetes 20:785–799
8. 1c affected by glycemic instability? Diabetes Care 26:2728–2733
9. Davidson JA, Holland WL, Roth MG et al (2016) Glucagon therapeutics: dawn of a new era for diabetes care. Diabetes Metab Res Rev. doi:10.1002/dmrr.2773
10. Wang MY, Chen L, Clark GO et al (2010) Leptin therapy in insulin deficient type 1 diabetes. Proc Natl Acad Sci U S A 107:4813–4819
11. Yu X, Park BH, Wang MY, Wang ZW, Unger RH (2008) Making insulin-deficient type 1 diabetic rodents thrive without insulin. Proc Natl Acad Sci U S A 105:14070–14075
12. Wang MY, Yan H, Shi Z et al (2015) Glucagon receptor antibody completely suppresses type 1 diabetes phenotype without insulin by disrupting a novel diabetogenic pathway. Proc Natl Acad Sci U S A 112:2503–2508
13. Orci L, Baetens D, Rufener C et al (1976) Hypertrophy and hyperplasia of somatostatin-containing D-cells in diabetes. Proc Natl Acad Sci U S A 173:1338–1342
14. Conarello SL, Jiang G, Mu J et al (2007) Glucagon receptor knock out mice are resistant to diet induced obesity and streptozotocin mediated beta cell loss and hyperglycemia. Diabetologia 50:142–150
15. Lee Y, Berglund ED, Yu X et al (2014) Hyperglycemia in rodent models of type 2 diabetes requires insulin-resistant alpha cells. Proc Natl Acad Sci U S A 111:13217–13222
16. Yan H, Gu W, Yang J et al (2009) Fully human monoclonal antibodies antagonizing the glucagon receptor improve glucose homeostasis in mice and monkeys. J Pharmacol Exp Ther 329:102–111